Cell MedX Corp. (CMXC)
USD 0.43
(0.0%)
USD 0.43
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | - USD | 0.0% |
| 2023 | - USD | 100.0% |
| 2022 | -8775.00 USD | 29.36% |
| 2021 | -12.42 Thousand USD | -123.94% |
| 2020 | 51.88 Thousand USD | -29.12% |
| 2019 | 73.2 Thousand USD | 578.23% |
| 2018 | 10.79 Thousand USD | 32.25% |
| 2017 | 8161.00 USD | 77.45% |
| 2016 | 4599.00 USD | 550.5% |
| 2015 | 707.00 USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - USD | 0.0% |
| 2024 FY | - USD | 0.0% |
| 2024 Q4 | - USD | 0.0% |
| 2024 Q3 | - USD | 0.0% |
| 2024 Q2 | - USD | 0.0% |
| 2023 Q2 | - USD | 100.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | -9367.00 USD | -6.75% |
| 2023 FY | - USD | 100.0% |
| 2023 Q4 | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 FY | -8775.00 USD | 29.36% |
| 2022 Q4 | -8775.00 USD | 0.0% |
| 2021 Q3 | 48.45 Thousand USD | -8.66% |
| 2021 FY | -12.42 Thousand USD | -123.94% |
| 2021 Q4 | - USD | -100.0% |
| 2021 Q1 | 54.46 Thousand USD | 4.97% |
| 2021 Q2 | 53.05 Thousand USD | -2.59% |
| 2020 Q2 | 77.78 Thousand USD | 10.67% |
| 2020 FY | 51.88 Thousand USD | -29.12% |
| 2020 Q1 | 70.28 Thousand USD | -3.98% |
| 2020 Q3 | 70.04 Thousand USD | -9.96% |
| 2020 Q4 | 51.88 Thousand USD | -25.92% |
| 2019 Q4 | 73.2 Thousand USD | 14.08% |
| 2019 Q1 | 13.95 Thousand USD | 29.28% |
| 2019 Q2 | 59.78 Thousand USD | 328.49% |
| 2019 FY | 73.2 Thousand USD | 578.23% |
| 2019 Q3 | 64.16 Thousand USD | 7.32% |
| 2018 Q3 | 29.58 Thousand USD | 0.62% |
| 2018 Q1 | 21.97 Thousand USD | 169.22% |
| 2018 FY | 10.79 Thousand USD | 32.25% |
| 2018 Q4 | 10.79 Thousand USD | -63.51% |
| 2018 Q2 | 29.39 Thousand USD | 33.81% |
| 2017 FY | 8161.00 USD | 77.45% |
| 2017 Q1 | 776.00 USD | -83.13% |
| 2017 Q2 | 3715.00 USD | 378.74% |
| 2017 Q3 | 2884.00 USD | -22.37% |
| 2017 Q4 | 8161.00 USD | 182.98% |
| 2016 Q1 | 1063.00 USD | 50.35% |
| 2016 FY | 4599.00 USD | 550.5% |
| 2016 Q4 | 4599.00 USD | 270.29% |
| 2016 Q3 | 1242.00 USD | 65.16% |
| 2016 Q2 | 752.00 USD | -29.26% |
| 2015 Q2 | -38.00 USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q4 | 707.00 USD | -51.11% |
| 2015 FY | 707.00 USD | 0.0% |
| 2015 Q3 | 1446.00 USD | 3905.26% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| RetinalGenix Technologies Inc. | - USD | NaN% |